Wird geladen...
Valsartan Orodispersible Tablets: Formulation, In vitro/In vivo Characterization
Valsartan orodispersible tablets have been developed at 40-mg dose, with the intention of facilitating administration to patients experiencing problems with swallowing and hopefully, improving its poor oral bioavailability. Work started with selecting drug compatible excipients depending on differen...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer US
2010
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2850465/ https://ncbi.nlm.nih.gov/pubmed/20112137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12249-009-9354-7 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|